All‐cause mortality · preterm or low birth weight infants
Formula showed no clear difference in all‐cause mortality compared with donor breast milk (moderate certainty).
1 finding from 1 review
All‐cause mortality · adults with severe aortic stenosis who are at a low surgical risk.
Transcatheter aortic valve implantation showed no clear difference in all‐cause mortality compared with surgical aortic valve replacement (moderate certainty).
1 finding from 1 review
Mortality Mortality at latest · infants with low birthweight
Kangaroo mother care probably leads to lower mortality at latest compared with conventional neonatal care (moderate certainty).
1 finding from 1 review
All cause‐mortality · cancer patients with afebrile neutropenia following chemotherapy
Summary of findings: quinolone prophylaxis probably leads to higher all cause‐mortality compared with TMP‐SMZ prophylaxis (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · preterm or low birth weight infants
The intervention showed no clear difference in all‐cause mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality low risk of bias Mortality · patients with preventing hepatitis A.
The intervention showed no clear difference in all‐cause mortality low risk of bias Mortality (high certainty).
1 finding from 1 review
Intervention not reported
Reported mortality, low risk of bias studies only · patients undergoing surgery
It is very uncertain whether the intervention changes reported mortality, low risk of bias studies only (very low certainty).
1 finding from 1 review
Mortality at 6 months · people with acute traumatic brain injury
It is very uncertain whether hypertonic saline changes mortality at 6 months compared with other intracranial pressure‐lowering agents (very low certainty).
1 finding from 1 review
Mortality-At any time · people who underwent a lower limb revascularisation
Neuraxial showed no clear difference in mortality-At any time compared with general anaesthesia (low certainty).
1 finding from 1 review
All‐cause mortality Up to 28 days following admission · the prevention and treatment of bleeding in patients without haemophilia
FIBRINOGEN: Therapeutic trials: intervention showed no clear difference in all‐cause mortality Up to 28 days following admission compared with inactive Control (moderate certainty).
1 finding from 1 review
Mortality at 30 days following the ingestion of paraquat · people with moderate to severe oral paraquat poisoning
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality at 12 months · adults with dementia following hip fracture surgery
It is very uncertain whether geriatrician‐led inpatient management changes mortality at 12 months compared with orthopaedic‐led inpatient management (very low certainty).
1 finding from 1 review
Mortality (short‐term) · people with acute traumatic brain injury
It is very uncertain whether hypertonic saline changes mortality (short‐term) compared with other intracranial pressure‐lowering agents (very low certainty).
1 finding from 1 review
Cancer mortality risk No. of participants: 17,448 (1 RCT) · Participants in trials with low risk of bias
Highest showed no clear difference in cancer mortality risk No. of participants: 17,448 (1 RCT) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Anti‐cytokine, all‐cause mortality ‐ low risk of bias studies · patients with sepsis, severe sepsis, septic shock
Monoclonal antibodies leads to lower anti‐cytokine, all‐cause mortality ‐ low risk of bias studies compared with placebo (high certainty).
1 finding from 1 review
All‐cause mortality ‐ sensitivity analysis · patients with sepsis, severe sepsis, septic shock
Monoclonal antibodies showed no clear difference in anti‐endotoxin, all‐cause mortality ‐ low risk of bias studies compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality Up to 28 days following admission · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number of deaths at 30 days following admission (30‐day mortality)a compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
28‐Day all cause mortality (adult studies) · adult patients with sepsis, severe sepsis and septic shock
Polyclonal intravenous immunoglobulin (IVIG) showed no clear difference in low risk of bias adult studies, by type of polyclonal IVIG,… compared with placebo or no intervention (high certainty).
3 findings from 1 review
RR 0.97 [0.81, 1.15]
5 studies · 945 participants
High
RR 1.02 [0.84, 1.24]
3 studies · 683 participants
High
RR 0.82 [0.56, 1.19]
2 studies · 262 participants
Moderate
All‐cause mortality, neonates, standard polyclonal IVIG · neonates with sepsis, severe sepsis and septic shock
Polyclonal intravenous immunoglobulin (IVIG) showed no clear difference in low risk of bias neonate studies, mortality all‐cause ‐ standard IVIG compared with placebo or no intervention (high certainty).
1 finding from 1 review
All-cause mortality (ACM) · Adults (any age) with a known number of remaining teeth, followed prospectively in cohort studies
In prospective cohorts, the multivariable-adjusted HR for all-cause mortality in edentulous adults (0 teeth) vs adults with 1-32 teeth was 1.30 (95% CI 1.21 to 1.40; 7 studies, I2=20%); GRADE per-analysis ratings reported in Supplementary File 7 (not available in provided sources).
4 findings from 1 review
Show 1 more finding